- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
OSSOPAN - 800mg - 40
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M05BX | B | Osseine-hydroxyapatite complex - 800mg | 1872 | 261372 | OSSOPAN | 800mg | 40 | Tablet, film coated | Oral | Mersaco | Swissco Services AG | Switzerland | 1,142,266 L.L | 23.08 | A2 | Pierre Fabre Pharma AG | Switzerland | 2/5/2024 | 0 |